Page 1

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON , D.C. 20549 FORM 20 - F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12 ( b ) OR 12 ( g ) OF THE SECURITIES EXCHANGE ACT OF 1934 ☑ OR ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31 , 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15 ( d ) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring this shell company report_ Commission file number 001-36349 Mw MediWound MEDIWOUND LTD . ( Exact name of Registrant as specified in its charter ) Not applicable ( Translation of Registrant's name into English ) ISRAEL ( Jurisdiction of incorporation or organization ) 42 Hayarkon Street Yavne , 8122745 Israel ( Address of principal executive offices ) Yaron Meyer , Adv . Executive Vice President , General Counsel and Corporate Secretary Telephone : +972 ( 77 ) 971-4100 E - mail : yaronm@mediwound.com MediWound Ltd. 42 Hayarkon Street Yavne , 8122745 Israel ( Name , telephone , e - mail and / or facsimile number and address of company contact person )